South San Francisco, CA, United States of America

Cheng Hu

This inventor holds 6 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Denali Therapeutics Inc.. Active years: 2021-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cheng Hu. Retrieved from https://idiyas.com/inventor/cheng-hu-xiy07joa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 100.0

 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Cheng Hu: Innovator in Therapeutics

Introduction

Cheng Hu is a prominent inventor based in South San Francisco, CA. He has made significant contributions to the field of therapeutics, holding a total of six patents. His work focuses on innovative methods and compositions aimed at improving health outcomes.

Latest Patents

Cheng Hu's latest patents include "Compounds, compositions and methods," which relates to methods and compositions for preventing or arresting cell death and/or inflammation. Another notable patent is "Kinase inhibitors and uses thereof," which discusses compounds and compositions, intermediates, processes for their preparation, and their use as kinase inhibitors.

Career Highlights

Cheng Hu is currently employed at Denali Therapeutics Inc., where he applies his expertise in developing therapeutic solutions. His work has been instrumental in advancing the understanding of cellular processes and therapeutic interventions.

Collaborations

Cheng collaborates with talented individuals such as Javier De Vicente Fidalgo and Anthony A Estrada, contributing to a dynamic research environment.

Conclusion

Cheng Hu's innovative work in therapeutics and his impressive portfolio of patents highlight his significant impact in the field. His contributions continue to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…